Why Kelatox® EDTA Chelation Suppositories? |
There are three questions people have about suppositories:
The answers are pretty simple...
EDTA is a synthetic amino acid and must be introduced directly into the bloodstream for maximum effectiveness. EDTA when taken orally must pass through the gastro intestinal system where the acid and enzymes in the stomach and intestine will cause the EDTA to break down and not be properly absorbed. This is why EDTA chelation therapy has been more successful when administered intravenously (IV) over the oral route of administration.
Suppositories provide virtually the same results as the IV without the needle, since the EDTA is absorbed by the colon wall and placed directly into the bloodstream, just as an IV treatment would. Kelatox suppositories are given at a lower dose than the IV, which lowers the risk of complications with liver and kidney function. They are safe enough to be given daily, thus increasing the amount of EDTA in the bloodstream at any given moment, making the suppository method more effective over time. View supportive details in the following medical study, click here.
| Requires MD |
No |
Yes |
No |
| Requires blood tests |
No |
Yes |
No |
| Requires liver and kidney function tests |
No |
Yes |
No |
| Typical Asorption |
5% |
100% |
95% |
| Average cost per dosage/day |
$0.67 (recommended three capsules daily) |
$125 |
$7.64 |
| Dosages required to equal 1 IV |
150 capsules |
1 IV treatment |
3 suppositories |
| Cost equivalent to 1 IV |
$34.50 |
$125 |
$22.90 |
| Cost over a month |
$276 |
$1000 |
$229 |
| Time to administer dose |
As long as it takes to swallow 150 capsules |
2-3 hours |
about a minute |
| Recommended treatment |
Daily |
30 Treatments |
90 suppositories |
| Total Cost (based on 30 IV treatments) |
$1035 |
$3750 |
$687 |
| * These are estimates. There is no way to accurately ascertain exact equivalents. |
IV EDTA CHelation Therapy
IV EDTA chelation therapy has been proven safe and effective as a treatment for coronary heart disease, atherosclerosis and other age-related diseases. The downside of IV therapy is you still need blood tests plus liver and kidney function tests before you can begin the treatment to ensure your safety. Dozens of scientific studies spanning 50 years prove that IV EDTA safely increases blood flow, alleviates symptoms of cardiovascular disease as well as removes heavy metals. Over the past decade, suppository administration of EDTA chelation therapy has emerged as virtually identical to the IV method on a medical level. Because the EDTA is absorbed through the colon and goes directly into the blood stream thereby bypassing the liver on first pass, suppositories provide the same benefits of IV ETDA therapy. The primary difference between IV and suppository is it requires roughly three suppositories to equal one IV treatment. The upside to the suppository method is it is a fraction of the cost of IV therapy and is done in the privacy of your own home without the need of medical supervision.
Oral Chelation Therapy
In regards to oral EDTA therapy, there are no scientific studies of any kind, to date, showing similar benefit using EDTA by mouth. Plus there's good reason to believe that prolonged use of high-dose oral EDTA may be harmful. First and foremost, EDTA is very poorly absorbed by mouth—only about five percent. It is theoretically possible to slowly absorb a substantial amount of EDTA by mouth over a prolonged period of time and receive some benefit, but there could be potential problems with that approach:
The unabsorbed 95 percent of EDTA remains within the digestive tract, mixing with undigested food and nutrients while passing on out of the body in stool. This unabsorbed EDTA tightly binds to and blocks absorption of many essential nutritional trace elements as it passes through the gastro intestinal tract. It blocks the uptake of zinc, manganese, chromium, vanadium, copper, chromium, molybdenum and other essential nutrients, potentially causing deficiencies.
Suppository and IV Administration of EDTA Chelation
Both the suppository and IV route of administration of EDTA have been proven safe. Since they will both deliver a greater dosage per application than oral EDTA, they both deliver greater benefits in a much shorter period of time compared to oral EDTA. Mineral supplementation is essential when using EDTA, but you should separate it from using EDTA by at least 8 hours so you do not remove what you are trying to replace. Since it is normally recommended to take oral EDTA 3 times daily, this time frame would not give your body ample time to breakdown and process your mineral supplementation before the EDTA would bind with the minerals and remove them from your body.
Since both the suppository and IV route of administration provide a direct path into the blood, this results in high therapeutic blood levels of EDTA. The oral route of administration of EDTA results in very low blood levels, subsequently resulting in little proven benefit for treatment of heavy metal removal or cardiovascular disease.
Daily use of EDTA by mouth may cause progressive deficiencies of zinc, manganese and other essential trace nutrients, which are an essential part of the body's antioxidant defenses. For example, superoxide dismutase (SOD), a very important intracellular antioxidant, cannot function without zinc and manganese. By inactivating antioxidant enzymes, daily EDTA by mouth actually worsens the very problems supposedly being treated.
Since EDTA remains outside of the cell wall and oral EDTA produces only a low concentration in the blood resulting in lower concentrations at cell surfaces throughout the body, it will only pull out through diffusion a small quantity of toxic heavy metals from inside cells. Conversely, the IV and suppository method result in much higher concentration levels giving the EDTA a much better opportunity to function properly.
|
